These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4151763)

  • 21. Pathophysiology of antipsychotic drug-induced movement disorders.
    Casey DE
    J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute extra pyramidal syndromes due to phenothiazines given with chloroquin--possible drug interaction.
    Khabya BL
    J Assoc Physicians India; 1976 Oct; 24(10):723. PubMed ID: 15962
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prolonged neurologic syndromes due to neuroleptic drugs and their treatment].
    Deniker P; Ginestet D
    Ann Med Interne (Paris); 1972; 123(8):787-9. PubMed ID: 4642195
    [No Abstract]   [Full Text] [Related]  

  • 24. Basal ganglia calcification: an effect of long-term phenothiazine therapy.
    Ahmed I
    J Kans Med Soc; 1979 Oct; 80(10):554. PubMed ID: 512439
    [No Abstract]   [Full Text] [Related]  

  • 25. Extrapyramidal syndrome associated with pipothiazines.
    Schiff AA
    J Clin Psychiatry; 1984 Mar; 45(3):145. PubMed ID: 6142038
    [No Abstract]   [Full Text] [Related]  

  • 26. Akathisia: a side effect to be remembered.
    Raskin DE
    Am J Psychiatry; 1972 Sep; 129(3):345-7. PubMed ID: 5053718
    [No Abstract]   [Full Text] [Related]  

  • 27. The management of schizophrenia.
    Bennett DH
    Br J Psychiatry; 1975; Spec No 9():48-54. PubMed ID: 241452
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of thiopropazate dihydrochloride (Dartalan) in treating persisting phenothiazine-induced choreo-athetosis and akathisia.
    Bullock RJ
    Med J Aust; 1972 Aug; 2(6):314-6. PubMed ID: 4404280
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chronic facio-lingual dyskinesia in patients treated with neuroleptics].
    Gralewski Z
    Neurol Neurochir Pol; 1973; 7(3):393-8. PubMed ID: 4714195
    [No Abstract]   [Full Text] [Related]  

  • 30. The continuing problem of extrapyramidal symptoms: strategies for avoidance and effective treatment.
    Gerlach J
    J Clin Psychiatry; 1999; 60 Suppl 23():20-4. PubMed ID: 10625196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Delayed-action neuroleptics (sustained-release neuroleptics). Indications, advantages and side effects].
    Predescu V; Nica-Udangiu St
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1975; 20(4):287-96. PubMed ID: 1085475
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased hexosaminidase activity in antipsychotic-induced extrapyramidal side effects: possible association with higher occurrence in bipolar disorder patients.
    Tunca Z; Resmi H; Ozkara HA; Ciliv G; Celtikci B; Alptekin K; Ozerdem A; Akdede BK; Baykara B; Birsoy B; Ergor G
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1214-20. PubMed ID: 18436361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Corneal and lens deposits due to treatment by phenothiazine type neuroleptics].
    Pouget R; Blayac JP; Largey B; Alric R; Castelnau D; Boulet J
    Ann Med Psychol (Paris); 1976 Mar; 1(3):403-7. PubMed ID: 7987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuroleptics. 10. Therapeutic problems.
    Barahona-Fernandes HJ; Cazzullo CL; Cocchi A; Denber HC; Freyhan FA; Klerman GL; Köknel O; Levine J; Saarma J; Sarteschi P; Vinar O; Wittenborn JR
    Mod Probl Pharmacopsychiatry; 1970; 5():148-56. PubMed ID: 4949818
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experience with long acting psychopharmaceutics in psychiatric hospitals].
    Reimer F
    Int Pharmacopsychiatry; 1974; 9(4):245-7. PubMed ID: 4156352
    [No Abstract]   [Full Text] [Related]  

  • 37. The prevalence of tardive dyskinesias in mental hospital patients.
    Fann WE; Davis JM; Janowsky DS
    Dis Nerv Syst; 1972 Mar; 33(3):182-6. PubMed ID: 5022453
    [No Abstract]   [Full Text] [Related]  

  • 38. Unusual complications of antipsychotic drugs.
    Diamond JM; Santos AB
    Am Fam Physician; 1982 Oct; 26(4):153-7. PubMed ID: 6127024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular complications of chlorpromazine therapy.
    Petrohelos MA; Tricoulis D
    Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of antipsychotics in children and adolescents.
    Findling RL; Steiner H; Weller EB
    J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.